Standard

Immunohistochemical assay of cellular cycle markers : An alternative to chip-diagnosis of breast cancer. / Petrov, S. V.; Orlova, R. V.; Raskin, G. A.; Khasanov, R. Sh.

In: Voprosy Onkologii, Vol. 53, No. 5, 2007, p. 526-530.

Research output: Contribution to journal › Article › peer-review

Harvard

Petrov, SV, Orlova, RV, Raskin, GA & Khasanov, RS 2007, 'Immunohistochemical assay of cellular cycle markers: An alternative to chip-diagnosis of breast cancer', Voprosy Onkologii, vol. 53, no. 5, pp. 526-530.

APA

Petrov, S. V., Orlova, R. V., Raskin, G. A., & Khasanov, R. S. (2007). Immunohistochemical assay of cellular cycle markers: An alternative to chip-diagnosis of breast cancer. Voprosy Onkologii, 53(5), 526-530.

Vancouver

Petrov SV, Orlova RV, Raskin GA, Khasanov RS. Immunohistochemical assay of cellular cycle markers: An alternative to chip-diagnosis of breast cancer. Voprosy Onkologii. 2007;53(5):526-530.

Author

Petrov, S. V. ; Orlova, R. V. ; Raskin, G. A. ; Khasanov, R. Sh. / Immunohistochemical assay of cellular cycle markers : An alternative to chip-diagnosis of breast cancer. In: Voprosy Onkologii. 2007 ; Vol. 53, No. 5. pp. 526-530.

BibTeX

@article{1fb6c6dde612491aa4c0e68c4e81d774,
title = "Immunohistochemical assay of cellular cycle markers: An alternative to chip-diagnosis of breast cancer",
abstract = "A new method of evaluation of immunohistochemical markers of cellular cycle (K-67, topoisomerase-11-α, P21/wafl), adhesion molecules (E-cadherin, CD33v6), oncoprotein HER-2, and estrogen and progesterone receptors of tumor is presented. High-precision count of tumor cells, which express each marker, was carried out using serial paraffin sections and Leica CTR5000 morphometric station and Leica Quin Plus program, to identify tumor sensitivity to anthracyclines and taxanes. Proliferative potential, tumor sensitivity to key chemical drugs and prognosis were evaluated on the basis of the evidence obtained and, in particular, the role of the proteins under study played in cellular cycle.",
author = "Petrov, {S. V.} and Orlova, {R. V.} and Raskin, {G. A.} and Khasanov, {R. Sh}",
year = "2007",
language = "English",
volume = "53",
pages = "526--530",
journal = "Вопросы онкологии",
issn = "0507-3758",
publisher = "Медицина",
number = "5",

}

RIS

TY - JOUR

T1 - Immunohistochemical assay of cellular cycle markers

T2 - An alternative to chip-diagnosis of breast cancer

AU - Petrov, S. V.

AU - Orlova, R. V.

AU - Raskin, G. A.

AU - Khasanov, R. Sh

PY - 2007

Y1 - 2007

N2 - A new method of evaluation of immunohistochemical markers of cellular cycle (K-67, topoisomerase-11-α, P21/wafl), adhesion molecules (E-cadherin, CD33v6), oncoprotein HER-2, and estrogen and progesterone receptors of tumor is presented. High-precision count of tumor cells, which express each marker, was carried out using serial paraffin sections and Leica CTR5000 morphometric station and Leica Quin Plus program, to identify tumor sensitivity to anthracyclines and taxanes. Proliferative potential, tumor sensitivity to key chemical drugs and prognosis were evaluated on the basis of the evidence obtained and, in particular, the role of the proteins under study played in cellular cycle.

AB - A new method of evaluation of immunohistochemical markers of cellular cycle (K-67, topoisomerase-11-α, P21/wafl), adhesion molecules (E-cadherin, CD33v6), oncoprotein HER-2, and estrogen and progesterone receptors of tumor is presented. High-precision count of tumor cells, which express each marker, was carried out using serial paraffin sections and Leica CTR5000 morphometric station and Leica Quin Plus program, to identify tumor sensitivity to anthracyclines and taxanes. Proliferative potential, tumor sensitivity to key chemical drugs and prognosis were evaluated on the basis of the evidence obtained and, in particular, the role of the proteins under study played in cellular cycle.

UR - http://www.scopus.com/inward/record.url?scp=36549016090&partnerID=8YFLogxK

M3 - Article

C2 - 18154114

AN - SCOPUS:36549016090

VL - 53

SP - 526

EP - 530

JO - Вопросы онкологии

JF - Вопросы онкологии

SN - 0507-3758

IS - 5

ER -

ID: 88358280